MFN2 and lung cancer: The downregulation of MFN2 in PAH as well as lung cancer, in part, appears to be tied to increased proteasomal degradation, which is triggered by PINK1-induced serine-442 MFN2 phosphorylation (Dasgupta et al., 2021).